- Home
- HEQ vs ICAD Comparison
HEQ vs ICAD Comparison
Compare HEQ & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEQ
- ICAD
- Stock Information
- Founded
- HEQ 2011
- ICAD 1984
- Country
- HEQ United States
- ICAD United States
- Employees
- HEQ N/A
- ICAD N/A
- Industry
- HEQ Investment Managers
- ICAD Medical/Dental Instruments
- Sector
- HEQ Finance
- ICAD Health Care
- Exchange
- HEQ Nasdaq
- ICAD Nasdaq
- Market Cap
- HEQ 127.0M
- ICAD 103.3M
- IPO Year
- HEQ N/A
- ICAD 1986
- Fundamental
- Price
- HEQ $10.64
- ICAD $3.72
- Analyst Decision
- HEQ
- ICAD Hold
- Analyst Count
- HEQ 0
- ICAD 1
- Target Price
- HEQ N/A
- ICAD N/A
- AVG Volume (30 Days)
- HEQ 43.1K
- ICAD 249.6K
- Earning Date
- HEQ 01-01-0001
- ICAD 08-12-2025
- Dividend Yield
- HEQ 9.78%
- ICAD N/A
- EPS Growth
- HEQ N/A
- ICAD N/A
- EPS
- HEQ N/A
- ICAD N/A
- Revenue
- HEQ N/A
- ICAD $19,528,000.00
- Revenue This Year
- HEQ N/A
- ICAD $3.60
- Revenue Next Year
- HEQ N/A
- ICAD N/A
- P/E Ratio
- HEQ N/A
- ICAD N/A
- Revenue Growth
- HEQ N/A
- ICAD 8.86
- 52 Week Low
- HEQ $9.08
- ICAD $1.18
- 52 Week High
- HEQ $11.84
- ICAD $4.02
- Technical
- Relative Strength Index (RSI)
- HEQ 59.68
- ICAD 49.12
- Support Level
- HEQ $10.45
- ICAD $3.58
- Resistance Level
- HEQ $10.56
- ICAD $3.92
- Average True Range (ATR)
- HEQ 0.08
- ICAD 0.14
- MACD
- HEQ 0.00
- ICAD -0.02
- Stochastic Oscillator
- HEQ 75.00
- ICAD 33.33
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.